Workflow
IonQ(IONQ) - 2024 Q3 - Earnings Call Transcript
IONQIonQ(IONQ)2024-11-07 00:08
Filings

Financial Data and Key Metrics - Revenue for Q3 2024 was 12.4million,exceedingthehigh−endoftheexpectedrangeof12.4 million, exceeding the high-end of the expected range of 9 million to 12million,representingmorethandoubletherevenuefromthesamequarterlastyear[10]−Thecompanyraiseditsfull−year2024revenueguidancetoarangeof12 million, representing more than double the revenue from the same quarter last year [10] - The company raised its full-year 2024 revenue guidance to a range of 38.5 million to 42.5million[11]−Q32024bookingswere42.5 million [11] - Q3 2024 bookings were 63.5 million, bringing year-to-date bookings to 72.8million,closetothetargetguidanceof72.8 million, close to the target guidance of 75 million to 95million[12][33]−NetlossforQ32024was95 million [12][33] - Net loss for Q3 2024 was 52.5 million, compared to 44.8millionintheprioryearperiod,includinganon−cashlossof44.8 million in the prior year period, including a non-cash loss of 3.9 million related to warrant liabilities [37] - Adjusted EBITDA loss for Q3 2024 was 23.7million,comparedto23.7 million, compared to 22.4 million in the prior year period [38] - Cash, cash equivalents, and investments as of September 30, 2024, were 382.8million[39]BusinessLineDataandKeyMetrics−Thecompanyannounceda382.8 million [39] Business Line Data and Key Metrics - The company announced a 54.5 million contract with the United States Air Force Research Lab and a 9millionrenewalwiththeUniversityofMaryland[11]−IonQhasexceededitsoriginalbookingstargetsforeachofthepastthreeyears,raisingorbeatingexpectationsin12outof13earningscalls[13]−Thecompanyisfocusingonquantumapplicationsinbiopharmaceuticaldrugdiscoveryandcomputer−aidedsimulationsforengineeringandmanufacturingindustries[19][20]−Quantumnetworkingisakeyfocus,withrecentcontractstotalingover9 million renewal with the University of Maryland [11] - IonQ has exceeded its original bookings targets for each of the past three years, raising or beating expectations in 12 out of 13 earnings calls [13] - The company is focusing on quantum applications in biopharmaceutical drug discovery and computer-aided simulations for engineering and manufacturing industries [19][20] - Quantum networking is a key focus, with recent contracts totaling over 60 million, including a 54.5milliondealwithAFRLanda54.5 million deal with AFRL and a 5.7 million contract with ARLIS [23] Market Data and Key Metrics - The company is expanding its presence in the quantum networking market, with McKinsey estimating quantum communication to become a 36billionmarketby2040[25]−IonQisleveragingpartnershipswithAstraZenecaandAnsystodevelopquantumapplicationsinbiopharmaceuticalsandengineering,targetingapotential36 billion market by 2040 [25] - IonQ is leveraging partnerships with AstraZeneca and Ansys to develop quantum applications in biopharmaceuticals and engineering, targeting a potential 2 trillion economic value by 2035 [21] Company Strategy and Industry Competition - IonQ is positioning itself as a leader in both quantum computing and quantum networking, with plans to expand into software applications [31][32] - The acquisition of Qubitekk, a quantum networking company, is expected to enhance IonQ's capabilities in quantum networking and expand its total addressable market [24][45] - The company is investing in R&D and manufacturing partnerships, including agreements with NKT Photonics and imec, to reduce hardware costs and improve system performance [28][30] Management Commentary on Operating Environment and Future Outlook - Management believes that early noisy quantum computers can provide value before perfection, giving IonQ a significant advantage in generating early cash flow [16] - The company is focused on profitable growth, positive free cash flow, and commercial quantum market leadership [40] - IonQ expects to continue its momentum in quantum networking and applications, with strong bookings and revenue growth anticipated for the future [43] Other Important Information - The company announced the achievement of ion-to-ion entanglement, a significant milestone in developing photonic interconnects [27] - IonQ is working on reducing the size, weight, and power of its quantum computers through partnerships with NKT Photonics and imec [29][30] Q&A Session Summary Question: Qubitekk Acquisition and Synergies - The acquisition of Qubitekk brings complementary technology and expands IonQ's total addressable market in quantum networking [45] - Qubitekk's existing contracts with telcos allow IonQ to move its quantum networking efforts from the lab to real-world testing [59] Question: Quantum Sensing and Future Market Focus - Quantum sensing is another potential market for IonQ, as it often requires quantum networking to transport quantum information [46] - The company is shifting its focus from government contracts to enterprise applications, particularly in biopharmaceuticals and engineering [62] Question: NKT Photonics Partnership and Commercialization - The partnership with NKT Photonics aims to reduce the cost and size of IonQ's quantum computers by developing next-generation laser systems [65][66] Question: OpEx and Team Expansion - The company is not making any changes to OpEx for the rest of the year and will discuss future OpEx plans during the Q4 earnings call [68] - IonQ is focusing on strategic growth and reallocating capital to areas with the highest potential impact [69]